- ¥113bn
- ¥104bn
- ¥39bn
- 58
- 27
- 77
- 57
Annual balance sheet for Hogy Medical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 20,549 | 14,364 | 18,862 | 19,419 | 22,005 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 11,390 | 11,340 | 11,962 | 12,765 | 11,445 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 41,322 | 35,290 | 40,290 | 43,025 | 44,200 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 52,794 | 52,759 | 51,555 | 45,712 | 45,763 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 105,644 | 98,967 | 102,180 | 100,041 | 97,895 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 7,590 | 9,348 | 11,134 | 8,241 | 10,381 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 9,766 | 19,008 | 18,574 | 13,929 | 23,571 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 95,878 | 79,959 | 83,606 | 86,112 | 74,324 |
| Total Liabilities & Shareholders' Equity | 105,644 | 98,967 | 102,180 | 100,041 | 97,895 |
| Total Common Shares Outstanding |